Finally, to assess clinical significance of these proteins, we collected clinical data from 12 newly diagnosed AML patients and analyzed the correlation between plasma TNFAIP8, TCL1A, WFDC1, and TNFSF8 protein levels and patient clinical features. The gene discussed is WFDC1; the disease is acute myeloid leukemia.